Natixis Raised By $926,961 Its Quest Diagnostics (DGX) Stake; CARRE FOUR SUPERMARC (CRERF) Shorts Increased By 11.9%

November 18, 2017 - By Adrian Erickson

Natixis increased Quest Diagnostics Inc (DGX) stake by 19.21% reported in 2017Q2 SEC filing. Natixis acquired 8,351 shares as Quest Diagnostics Inc (DGX)’s stock rose 10.72%. The Natixis holds 51,822 shares with $5.76M value, up from 43,471 last quarter. Quest Diagnostics Inc now has $12.69 billion valuation. The stock increased 0.06% or $0.06 on November 17, reaching $93.04. About 2.01M shares traded or 55.81% up from the average. Quest Diagnostics Inc (NYSE:DGX) has risen 39.04% since November 18, 2016 and is uptrending. It has outperformed by 22.34% the S&P500.

CARRE FOUR SUPERMARC (OTCMKTS:CRERF) had an increase of 11.9% in short interest. CRERF’s SI was 703,400 shares in November as released by FINRA. Its up 11.9% from 628,600 shares previously. With 1,700 avg volume, 414 days are for CARRE FOUR SUPERMARC (OTCMKTS:CRERF)’s short sellers to cover CRERF’s short positions. It closed at $19.44 lastly. It is down 0.00% since November 18, 2016 and is . It has underperformed by 16.70% the S&P500.

Carrefour SA is a France-based company that is primarily engaged in retail distribution sector. The company has market cap of $15.06 billion. The Firm operates a network of hypermarkets, supermarkets, hard discount stores, convenience stores and cash-and-carry outlets and offers e-commerce services. It currently has negative earnings. The Company’s hypermarkets named Carrefour offer a range of food and non-food products.

Among 20 analysts covering Quest Diagnostics (NYSE:DGX), 7 have Buy rating, 2 Sell and 11 Hold. Therefore 35% are positive. Quest Diagnostics had 54 analyst reports since August 4, 2015 according to SRatingsIntel. Argus Research initiated Quest Diagnostics Inc (NYSE:DGX) rating on Friday, May 12. Argus Research has “Hold” rating and $102 target. Mizuho maintained the shares of DGX in report on Monday, June 5 with “Buy” rating. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, October 17. Robert W. Baird maintained the stock with “Hold” rating in Thursday, October 5 report. The rating was upgraded by UBS to “Buy” on Monday, November 14. The rating was upgraded by Zacks to “Hold” on Tuesday, August 18. On Friday, January 29 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The firm has “Buy” rating given on Thursday, October 26 by Canaccord Genuity. The firm has “Neutral” rating given on Wednesday, August 31 by Mizuho. The firm has “Neutral” rating given on Thursday, March 16 by Bank of America.

Investors sentiment decreased to 0.99 in 2017 Q2. Its down 0.05, from 1.04 in 2017Q1. It dived, as 38 investors sold DGX shares while 200 reduced holdings. 78 funds opened positions while 158 raised stakes. 113.89 million shares or 2.51% less from 116.82 million shares in 2017Q1 were reported. John G Ullman Inc owns 49,539 shares. U S Invsts, Texas-based fund reported 5,074 shares. Dynamic Cap Mgmt Limited invested in 0.68% or 27,183 shares. 100 were reported by Grp One Trading Lp. Seaward Management Partnership has invested 0.06% of its portfolio in Quest Diagnostics Inc (NYSE:DGX). Moreover, Boston Ltd Liability Corporation has 0.46% invested in Quest Diagnostics Inc (NYSE:DGX) for 177,972 shares. Franklin Resources invested in 0.05% or 940,076 shares. First Republic Mngmt holds 0% or 5,460 shares in its portfolio. Lowe Brockenbrough holds 28,420 shares or 0.5% of its portfolio. Heartland Incorporated holds 0.73% or 102,394 shares in its portfolio. Assets Inv Limited Liability holds 15,000 shares or 0.34% of its portfolio. Rockefeller Fincl Services Inc, New York-based fund reported 3,326 shares. Old Second Savings Bank Of Aurora holds 500 shares. Peapack Gladstone Financial holds 4,329 shares. Boston Prtnrs, Massachusetts-based fund reported 853,537 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>